Insights Widest with the analysis, Proactive gives perspectives that others don't.

cannabis plants Zoetic International makes rapid progress with CBD business

Zoetic grows its own hemp and sells CBD products in the US and the UK

1 hour, 21 minutes ago
Deep dive

Zynerba in exciting run-up to clinical readouts on CBD skin gel Zygel to...

With topline data from the CONNECT-FX trial on the way, investors are eyeing opportunities...

17 hours, 44 minutes ago
Deep dive

Genprex gene therapy candidate Oncoprex fast-tracking for non-small cell...

The US FDA has given its approval to a therapy combination with EGFR inhibitor osimertinib -...

2 days, 4 hours ago

Delta 9 Cannabis joins short list of profitable cannabis companies by...

With quarter-over-quarter growth and near-term catalysts that position the company to deliver...

1 week, 1 day ago
Deep dive

Dyadic on course to disrupt the status quo in manufacturing biologic...

The company applies its proprietary C1 gene expression platform to speed up the development of...

1 week, 2 days ago


Full interview: LexaGene hits milestone by having pre-commercial device in...

LexaGene (CVE: LXG- OTCQB: LXXGF) CEO Dr Jack Regan joined Steve Darling from Proactive Vancouver with news the company now has one of their devices that tests for COVID-19 and other respiratory pathogens being used at the Dartmouth-Hitchcock Medical Center in Hanover, New Hampshire. Regan...

20 hours, 45 minutes ago

Join Proactive

Get ahead of the curve

First with the equities news

Get our market previews and stories before the main networks.

Widest with the analysis

Not just the FTSE. Read about
opportunities from the whole
equities market.

Closest to the source

Hear directors at first-hand
or meet them in person at our events.

In at the start

Watch IPOs and access on the same terms as the institutions.